Vas Narasimhan

Novartis Outlines ‘Pure Play’ Innovative Medicines Strategy and Focused R&D Pipeline at London Event

(IN BRIEF) Novartis, a leading pharmaceutical company, presented its 'pure play' innovative medicines strategy and focused Research and Development (R&D)…

5 months ago

Novartis, Molecular Partners: Ensovibep has the potential to be an important new treatment option in the combat of rapidly evolving SARS-CoV-2 pandemic

Topline results from the randomized EMPATHY Part A study in acute COVID-19 ambulatory patients comparing single intravenous doses of ensovibep,…

2 years ago

Novartis welcomes new Chief Legal Officer Karen L. Hale

(PRESS RELEASE) BASEL, 22-Mar-2021 — /EuropaWire/ — Swiss multinational pharmaceutical Novartis appoints Karen L. Hale as Chief Legal Officer. She…

3 years ago

Francesco Balestrieri appointed ad-interim CEO of Sandoz reporting directly to Vas Narasimhan, CEO, Novartis

(PRESS RELEASE) BASEL, 15-Mar-2019 — /EuropaWire/ — Sandoz's current Region Head Europe Francesco Balestrieri has just been appointed ad-interim CEO…

5 years ago

Sandoz appoints Vas Narasimhan as Head of Sandoz Biopharmaceuticals & Oncology Injectables

Munich, Germany, 28-3-2014 — /EuropaWire/ — Sandoz announced today that Vasant (Vas) Narasimhan, MD, MPP, has been appointed Head of Sandoz Biopharmaceuticals &…

10 years ago